142 related articles for article (PubMed ID: 2538433)
1. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide.
Stack MS; Gray RD
J Biol Chem; 1989 Mar; 264(8):4277-81. PubMed ID: 2538433
[TBL] [Abstract][Full Text] [Related]
2. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
Stack MS; Emberts CG; Gray RD
Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
[TBL] [Abstract][Full Text] [Related]
3. The effect of pH, temperature, and D2O on the activity of porcine synovial collagenase and gelatinase.
Stack MS; Gray RD
Arch Biochem Biophys; 1990 Sep; 281(2):257-63. PubMed ID: 2168159
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of purified collagenase from alkali-burned rabbit corneas.
Burns FR; Stack MS; Gray RD; Paterson CA
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1569-75. PubMed ID: 2545645
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mammalian collagenases by thiol-containing peptides.
Gray RD; Miller RB; Spatola AF
J Cell Biochem; 1986; 32(1):71-7. PubMed ID: 3021790
[TBL] [Abstract][Full Text] [Related]
6. Cleavage specificity of type IV collagenase (gelatinase) from human skin. Use of synthetic peptides as model substrates.
Seltzer JL; Weingarten H; Akers KT; Eschbach ML; Grant GA; Eisen AZ
J Biol Chem; 1989 Nov; 264(33):19583-6. PubMed ID: 2555325
[TBL] [Abstract][Full Text] [Related]
7. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.
Murphy G; Reynolds JJ; Bretz U; Baggiolini M
Biochem J; 1982 Apr; 203(1):209-21. PubMed ID: 6285893
[TBL] [Abstract][Full Text] [Related]
8. Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain.
Stack S; Gray RD; Pizzo SV
Biochemistry; 1991 Feb; 30(8):2073-7. PubMed ID: 1847824
[TBL] [Abstract][Full Text] [Related]
9. Rapid optimization of enzyme substrates using defined substrate mixtures.
Berman J; Green M; Sugg E; Anderegg R; Millington DS; Norwood DL; McGeehan J; Wiseman J
J Biol Chem; 1992 Jan; 267(3):1434-7. PubMed ID: 1309783
[TBL] [Abstract][Full Text] [Related]
10. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
11. Eriochrome black T inhibition of human skin collagenase, but not gelatinase, using both protein and synthetic substrates.
Seltzer JL; Eschbach ML; Winberg JO; Bauer EA; Eisen AZ; Weingarten H
Coll Relat Res; 1987 Dec; 7(6):399-407. PubMed ID: 2833373
[TBL] [Abstract][Full Text] [Related]
12. Clostridium histolyticum collagenase: development of new thio ester, fluorogenic, and depsipeptide substrates and new inhibitors.
Vencill CF; Rasnick D; Crumley KV; Nishino N; Powers JC
Biochemistry; 1985 Jun; 24(13):3149-57. PubMed ID: 2992578
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
14. Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acid.
Darlak K; Miller RB; Stack MS; Spatola AF; Gray RD
J Biol Chem; 1990 Mar; 265(9):5199-205. PubMed ID: 2156864
[TBL] [Abstract][Full Text] [Related]
15. Matrix degrading proteinases from human granulocytes: type I, II, III collagenase, gelatinase and type IV, V-collagenase. A survey of recent findings and inhibition by gamma-anticollagenase.
Tschesche H; Fedrowitz J; Kohnert U; Michaelis J; Macartney HW
Folia Histochem Cytobiol; 1986; 24(2):125-31. PubMed ID: 3021541
[TBL] [Abstract][Full Text] [Related]
16. Increased collagenase and gelatinase activities in keratoconus.
Kao WW; Vergnes JP; Ebert J; Sundar-Raj CV; Brown SI
Biochem Biophys Res Commun; 1982 Aug; 107(3):929-36. PubMed ID: 6291521
[No Abstract] [Full Text] [Related]
17. Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides.
Seltzer JL; Akers KT; Weingarten H; Grant GA; McCourt DW; Eisen AZ
J Biol Chem; 1990 Nov; 265(33):20409-13. PubMed ID: 2173706
[TBL] [Abstract][Full Text] [Related]
18. Ovostatin: a novel proteinase inhibitor from chicken egg white. II. Mechanism of inhibition studied with collagenase and thermolysin.
Nagase H; Harris ED
J Biol Chem; 1983 Jun; 258(12):7490-8. PubMed ID: 6305943
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of Type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens.
Miller EJ; Harris ED; Chung E; Finch JE; McCroskery PA; Butler WT
Biochemistry; 1976 Feb; 15(4):787-92. PubMed ID: 174719
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the peptide substrate specificities of interstitial collagenase and 92-kDa gelatinase. Implications for substrate optimization.
McGeehan GM; Bickett DM; Green M; Kassel D; Wiseman JS; Berman J
J Biol Chem; 1994 Dec; 269(52):32814-20. PubMed ID: 7806505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
